About
Technology
Issues
FAQ
Links
Official Page
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.